PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsklebsiella infections
MeSH D007710 - klebsiella infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004756:Enterobacteriaceae infections
38 Companies
7 Drugs
$
Success rate
D007710: 
Klebsiella infections
164 Companies
75 Drugs
$
Success rate
D012226:Rhinoscleroma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsAmikacin Amikacin  1994-11-30   
Gentamicin Gentamicin  1983-08-11   
Able LaboratoriesPhenazopyridine, Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim Phenazopyridine  2001-06-26   
Accord HealthcareTigecycline Tigecycline  2018-01-18   
Tigecycline Tigecycline Accord  2020-04-17   
Alcon ResearchGentamicin Gentamicin  1985-11-25   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1986-11-17   
Neomycin, Polymyxin b Statrol  1984-11-30   
ALK-AbellóCiprofloxacin Otiprio 2029-04-21 2015-12-10   
Allegis PharmaceuticalsTrimethoprim Primsol  1995-06-23   
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
100%
2/2
Phase 3
98%
62/63
Approved: 61Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Alcon Research
Dexamethasone
Allergan
Avibactam,
Ceftazidime,
Ciprofloxacin,
Gatifloxacin,
Hydrocortisone,
Hydrocortisone butyrate,
Hydrocortisone probutate,
Levofloxacin,
Ofloxacin,
Prednisolone,
Prednisolone tebutate
1
2
3
4
5
6
...
11
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use